News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,512 Results
Type
Article (66140)
Company Profile (205)
Press Release (681144)
Multimedia
Podcasts (144)
Webinars (23)
Section
Business (205892)
Career Advice (3417)
Deals (35918)
Drug Delivery (131)
Drug Development (84391)
Employer Resources (190)
FDA (17714)
Job Trends (16212)
News (356402)
Policy (36922)
Tag
Academia (2939)
Academic (2)
Accelerated approval (17)
Adcomms (33)
Allergies (118)
Alliances (53327)
ALS (135)
Alzheimer's disease (1623)
Antibody-drug conjugate (ADC) (195)
Approvals (17710)
Artificial intelligence (415)
Autoimmune disease (47)
Automation (23)
Bankruptcy (375)
Best Places to Work (12139)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (129)
Bladder cancer (115)
Brain cancer (46)
Breast cancer (425)
Cancer (3470)
Cardiovascular disease (306)
Career advice (2903)
Career pathing (36)
CAR-T (226)
CDC (47)
Cell therapy (606)
Cervical cancer (28)
Clinical research (69649)
Collaboration (1258)
Company closure (4)
Compensation (591)
Complete response letters (50)
COVID-19 (2904)
CRISPR (75)
C-suite (500)
Cystic fibrosis (128)
Data (3714)
Decentralized trials (2)
Denatured (44)
Depression (96)
Diabetes (409)
Diagnostics (6853)
Digital health (29)
Diversity (7)
Diversity, equity & inclusion (47)
Drug discovery (188)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (182)
Earnings (83456)
Editorial (52)
Employer branding (23)
Employer resources (163)
Events (108371)
Executive appointments (945)
FDA (19910)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1107)
Gene editing (158)
Generative AI (38)
Gene therapy (488)
GLP-1 (968)
Government (5158)
Grass and pollen (7)
Guidances (332)
Healthcare (19811)
HIV (46)
Huntington's disease (31)
IgA nephropathy (51)
Immunology and inflammation (218)
Immuno-oncology (17)
Indications (46)
Infectious disease (3121)
Inflammatory bowel disease (176)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (158)
Interviews (660)
IPO (16425)
IRA (58)
Job creations (4440)
Job search strategy (2382)
Kidney cancer (14)
Labor market (64)
Layoffs (615)
Leadership (30)
Legal (9324)
Liver cancer (89)
Longevity (12)
Lung cancer (507)
Lymphoma (251)
Machine learning (22)
Management (63)
Manufacturing (546)
MASH (115)
Medical device (13954)
Medtech (13972)
Mergers & acquisitions (20296)
Metabolic disorders (1042)
Multiple sclerosis (116)
NASH (23)
Neurodegenerative disease (178)
Neuropsychiatric disorders (48)
Neuroscience (2501)
NextGen: Class of 2025 (7132)
Non-profit (5011)
Now hiring (44)
Obesity (525)
Opinion (300)
Ovarian cancer (111)
Pain (152)
Pancreatic cancer (145)
Parkinson's disease (211)
Partnered (25)
Patents (377)
Patient recruitment (264)
Peanut (56)
People (59243)
Pharmaceutical (51)
Pharmacy benefit managers (24)
Phase I (21372)
Phase II (30376)
Phase III (23251)
Pipeline (2435)
Policy (272)
Postmarket research (2926)
Preclinical (9304)
Press Release (71)
Prostate cancer (171)
Psychedelics (49)
Radiopharmaceuticals (264)
Rare diseases (590)
Real estate (6553)
Recruiting (74)
Regulatory (25670)
Reports (53)
Research institute (2635)
Resumes & cover letters (529)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (119)
Series A (182)
Series B (136)
Service/supplier (11)
Sickle cell disease (73)
Special edition (24)
Spinal muscular atrophy (163)
Sponsored (40)
Startups (3862)
State (2)
Stomach cancer (17)
Supply chain (93)
Tariffs (82)
The Weekly (98)
Vaccines (989)
Venture capital (62)
Weight loss (359)
Women's health (53)
Worklife (21)
Date
Today (115)
Last 7 days (453)
Last 30 days (2241)
Last 365 days (31721)
2025 (22179)
2024 (35704)
2023 (40299)
2022 (51390)
2021 (56013)
2020 (55317)
2019 (49219)
2018 (37487)
2017 (34936)
2016 (34627)
2015 (39812)
2014 (33839)
2013 (30171)
2012 (30838)
2011 (31115)
2010 (29549)
Location
Africa (1075)
Alabama (76)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (45430)
Australia (7729)
California (8228)
Canada (2639)
China (820)
Colorado (365)
Connecticut (369)
Delaware (208)
Europe (102551)
Florida (1293)
Georgia (293)
Hawaii (2)
Idaho (63)
Illinois (729)
India (43)
Indiana (405)
Iowa (17)
Japan (266)
Kansas (114)
Kentucky (33)
Louisiana (19)
Maine (75)
Maryland (1130)
Massachusetts (6050)
Michigan (290)
Minnesota (477)
Mississippi (4)
Missouri (111)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2376)
New Mexico (29)
New York (2296)
North Carolina (1228)
North Dakota (10)
Northern California (3695)
Ohio (268)
Oklahoma (18)
Oregon (38)
Pennsylvania (1754)
Puerto Rico (18)
Rhode Island (41)
South America (1451)
South Carolina (45)
South Dakota (1)
Southern California (3158)
Tennessee (136)
Texas (1295)
United States (30704)
Utah (264)
Virginia (221)
Washington D.C. (78)
Washington State (696)
West Virginia (4)
Wisconsin (73)
747,512 Results for "la jolla institute for allergy and immunology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
La Jolla Institute for Immunology and RevolKa started a Research Collaboration
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology agreed to start a research collaboration to create antigens for the next-generation vaccines to deliver innovative solutions to unmet medical need in infectious diseases.
April 18, 2024
·
2 min read
Press Releases
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress
June 9, 2025
·
2 min read
Press Releases
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
June 2, 2025
·
5 min read
Allergies
Regeneron’s Antibodies Block Cat and Birch Allergies With ‘Robust Activity’
Regeneron’s antibody duos significantly lowered eye itching and redness, as well as pin prick reactivity, in people with cat and birch allergies. Still, BMO Capital Markets expressed uncertainty about the assets’ “commercial potential in a highly generic market.”
September 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
KalVista Pharmaceuticals to Present New Sebetralstat Data at the European Academy of Allergy and Clinical Immunology Congress 2025
June 5, 2025
·
6 min read
Press Releases
Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress
June 3, 2025
·
5 min read
Job Trends
California’s $23.9M in Life Sciences Grants Could Add 10,000 Jobs in LA Area
Four Los Angeles County life sciences projects are receiving funding to support goals that include adding jobs, creating multitenant facilities for graduation-stage companies, financially supporting emerging businesses and attracting large employers to the area.
September 10, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Astria Therapeutics Announces Positive Initial Results from the ALPHA-SOLAR Long-Term Open-Label Trial of Navenibart in Hereditary Angioedema Patients at the European Academy of Allergy and Clinical Immunology Annual Congress
June 16, 2025
·
9 min read
Press Releases
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
June 16, 2025
·
9 min read
Press Releases
Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum
September 3, 2025
·
1 min read
1 of 74,752
Next
